Variations in cortical thickness with dementia severity in Alzheimer's disease

Neuroscience Letters
Kiho ImDuk L Na

Abstract

Previous magnetic resonance imaging (MRI) studies have used volumetric methods to investigate cerebral atrophy and showed its linear pattern with the measure of dementia severity in Alzheimer's disease (AD). This study analyzed the phase- and region-specific changes in cortical thickness with dementia severity. In 43 normal controls and 60 AD patients with clinical dementia rating (CDR) (0.5, n=21; 1, n=28; 2, n=11), the cortical thickness was measured using automated surface-based analysis of MRI data. Statistical analyses were performed to investigate overall the hemispheric mean thicknesses as well as the topography of cortical atrophy based on vertices in the groups. No significant difference in cortical thickness was observed for the mild (from CDR=0.5 to 1) stage of dementia. In contrast, a significant reduction of cortical thickness occurred from CDR=1 to 2. Topographic analysis of cortical atrophy showed that the significant cortical thinning in CDR=0.5 relative to normal was found in most association cortices, with this being more extensive than previously reported. There were significant cortical atrophies between CDR=1 and 2 in the frontal, inferolateral temporal, inferior parietal lobule, medial occipital, and poste...Continue Reading

References

Mar 1, 1994·Journal of Computer Assisted Tomography·D L CollinsA C Evans
Dec 1, 1996·Brain : a Journal of Neurology·N C FoxM N Rossor
Jun 9, 1998·IEEE Transactions on Medical Imaging·J G SledA C Evans
Mar 22, 2002·NeuroImage·Christopher R GenoveseThomas Nichols
Sep 29, 2004·Medical Image Analysis·Steven RobbinsSue Whitesides
Jan 13, 2006·Archives of Neurology·William R MarkesberyDavid R Wekstein
Sep 30, 2006·Brain : a Journal of Neurology·Vivek SinghNoor Jehan Kabani

❮ Previous
Next ❯

Citations

Jul 9, 2010·Journal of the International Neuropsychological Society : JINS·Richard E FryeSusan Landry
Jul 6, 2010·Journal of the International Neuropsychological Society : JINS·G Sánchez-BenavidesJ Peña-Casanova
Nov 8, 2012·PloS One·Zhijun YaoUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Feb 26, 2013·Brain : a Journal of Neurology·Cédric AnnweilerManuel Montero-Odasso
Nov 18, 2014·Biomarkers in Medicine·Elizabeth G KehoeArun L W Bokde
May 3, 2012·Neuroimaging Clinics of North America·Vivek PrabhakaranHoward Rowley
Jan 17, 2017·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Philipp M SummersAndy Y Shih
Apr 7, 2017·Brain Sciences·Lauren Zajac Behalf Of The Alzheimer's Disease Neuroimaging Initiative
Jun 1, 2018·American Journal of Alzheimer's Disease and Other Dementias·Suping CaiLiyu Huang
Nov 11, 2020·Statistics in Medicine·Xiaoqing WangHongtu Zhu
Feb 26, 2021·Journal of the American Statistical Association·Xiangnan FengHongtu Zhu
Mar 7, 2021·International Journal of Molecular Sciences·Wieke M van Oostveen, Elizabeth C M de Lange
Oct 17, 2021·The European Journal of Neuroscience·Gonzalo FornoMichael Hornberger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.